Add blog to your RSS reader
Get blog updates by emailPopular Topics
All Topics
- 401k
- Advertising
- Bankruptcy
- Business Law
- Business organizations
- CARES Act
- collateralized mortgage-backed securities "CMBS"
- Commercial Lease
- commerical real estate
- compliance
- Contract
- Contractual disputes
- Copyright, Trademark and Other Intellectual Property
- coronavirus
- Corporate Governance
- Corporate Law
- COVID-19
- Delaware corporate law
- Delaware Law
- Department of Labor (DOL)
- Digital Advertising
- Employee Benefits
- Employee Practices
- Employee Retirement Income Security Act "ERISA"
- employees
- Employment
- Estate Planning
- event of default
- Exemptions
- Families First Coronavirus Response Act "FFCRA"
- FDA
- Federal Laws & Regulations
- Force Majeure
- FTC
- HIPAA
- Insurance Company
- Insurance Coverage
- Intellectual Property
- IRS
- Law
- Laws
- Legislation
- lender
- Liquidity
- Litigation
- LLC
- Loans
- MAE
- Main Street
- Main Street Loans
- New York
- Notice
- Ordinary Course Covenant
- paid family leave
- pandemic
- Paycheck Protection Program (PPP)
- Payroll Protection Program (PPP)
- Privacy
- Property Insurance
- Public Companies
- Public M&A
- Q&A
- Real Estate
- Real Estate Litigation
- retail
- Retirement Plan
- SEC
- Shareholder Activism
- shelter in place
- Small business
- Small Business Administration (SBA)
- Social Media
- Social Media Marketing
- State Law
- Sweepstakes Law
- Sweeptstakes Contest
- Tax
- Tax Cuts and Jobs Act
- Telemarketing
- Telemarketing Law
- Trademarks
- webinar
Recent Posts
- COVID-19 Resource Guide
- Mark Limardo and Michael Passarella Present Webinar on the Paycheck Protection Program 2.0
- Delaware Chancery Court Provides Important Guidance on COVID-19’s Impact on a Buyer’s Obligation to Close:
- Olshan Branding Management and Protection Attorneys Present Webinar on Marketing in the COVID-19 Era to the Bronx Third Avenue BID
- Webinar - Retail Marketing Compliance in Post-COVID Era
- Your Estate Tax Exemption - Use It or Lose It
- Tax Decoupling During COVID-19
- The Continuing Reopening of New York – An Overview of Relevant New York, CDC, OSHA and EEOC Guidelines
- PPP Loan Forgiveness Application Revised
- New York’s Executive Orders 202.8 and 202.28 Should Not Stop Commercial Lease Enforcement, Though New York City Legislation Sets Limitations on Landlords Seeking Recovery From Personal Guarantors for Tenant Defaults
Archives
- January 2021
- December 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
Contact Us
(212) 451-2300
info@olshanlaw.com
www.olshanlaw.com
COVID-19 Legal Resources
Olshan Frome Wolosky LLP is gathering information related to COVID-19 issues and concerns to assist clients in navigating the national and New York states of emergency.
We will continue to prepare updates during this fluid situation. Clients and friends are encouraged to contact us with specific legal or operational questions or issues.
Showing 3 posts in FTC.
SEC Brings Enforcement Actions Against Companies for Misleading COVID-19 Claims
The U.S. Securities and Exchange Commission (the “SEC”) filed enforcement actions on May 14, 2020, against two unrelated companies, Turbo Global Partners, Inc. (“Turbo”) and Applied BioSciences Corp. (“APPB”). The SEC charged both companies with securities fraud based on alleged materially misleading statements that the companies were offering and shipping products to combat the coronavirus (COVID-19). These actions taken by the SEC are consistent with approaches taken by other regulators, including the Federal Trade Commission and Food and Drug Administration (the “FDA”), with regard to misleading statements made in connection with coronavirus-related products. On the whole, regulators appear to be particularly cognizant of businesses and individuals seeking to take improper advantage of the circumstances created by the global pandemic, and as such are taking action against such companies and individuals. Read More ›
FDA and FTC Send Warning Letters to Companies Claiming That Products Can Help Boost Immune Systems Relating to Coronavirus Prevention
The FDA and FTC have issued joint warning letters to companies selling products that they claim are able to treat or prevent coronavirus. The regulators sent the first set of such warning letters to several companies on March 6, 2020 and have continued to send such warning letters since. Read More ›
FTC Chairman Simons Releases Statement Regarding Ongoing Work of the Consumer Production Bureau During COVID-19 Pandemic
FTC Chairman Joe Simons has released a statement addressing the FTC’s ongoing efforts to enforce consumer protections laws during the coronavirus pandemic. Read More ›